European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS).

HRVWI PACNS Vasculitis angiitis angiography cerebrovascular immunosuppression large arteries magnetic resonance imaging steroid stroke

Journal

European stroke journal
ISSN: 2396-9881
Titre abrégé: Eur Stroke J
Pays: England
ID NLM: 101688446

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 27 11 2023
pubmed: 30 10 2023
entrez: 30 10 2023
Statut: ppublish

Résumé

The European Stroke Organisation (ESO) guideline on Primary Angiitis of the Central Nervous System (PACNS), developed according to ESO standard operating procedures (SOP) and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology, was elaborated to assist clinicians in the diagnostic and treatment pathway of patients with PACNS in their decision making. A working group involving vascular neurologists, neuroradiologists, rheumatologists, a neuropathologist and a methodologist identified 17 relevant clinical questions; these were addressed according to the patient/population, intervention, comparison and outcomes (PICO) framework and systematic literature reviews were performed. Notably, each PICO was addressed with respect to large vessel (LV)-PACNS and small vessel (SV)-PACNS. Data to answer many questions were scarce or lacking and the quality of evidence was very low overall, so, for some PICOs, the recommendations reflect the ongoing uncertainty. When the absence of sufficient evidence precluded recommendations, Expert Consensus Statements were formulated. In some cases, this applied to interventions in the diagnosis and treatment of PACNS which are embedded widely in clinical practice, for example patterns of cerebrospinal fluid (CSF) and Magnetic Resonance Imaging (MRI) abnormalities. CSF analysis for hyperproteinorrachia and pleocytosis does not have evidence supporting their use as diagnostic tools. The working group recommended that caution is employed in the interpretation of non-invasive vascular imaging due to lack of validation and the different sensitivities in comparison with digital subtraction angiography (DSA) and histopathological analyses. Moreover, there is not a neuroimaging pattern specific for PACNS and neurovascular issues are largely underreported in PACNS patients. The group's recommendations on induction and maintenance of treatment and for primary or secondary prevention of vascular events also reflect uncertainty due to lack of evidence. Being uncertain the role and practical usefulness of current diagnostic criteria and being not comparable the main treatment strategies, it is suggested to have a multidisciplinary team approach in an expert center during both work up and management of patients with suspected PACNS. Highlighting the limitations of the currently accepted diagnostic criteria, we hope to facilitate the design of multicenter, prospective clinical studies and trials. A standardization of neuroimaging techniques and reporting to improve the level of evidence underpinning interventions employed in the diagnosis and management of PACNS. We anticipate that this guideline, the first comprehensive European guideline on PACNS management using GRADE methodology, will assist clinicians to choose the most effective management strategy for PACNS.

Identifiants

pubmed: 37903069
doi: 10.1177/23969873231190431
pmc: PMC10683718
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

842-879

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

AJNR Am J Neuroradiol. 2017 Oct;38(10):1917-1922
pubmed: 28751515
Stroke. 2012 Jan;43(1):259-61
pubmed: 21980209
JAMA Neurol. 2017 Jan 01;74(1):100-109
pubmed: 27893883
Arch Neurol. 2009 Jun;66(6):704-9
pubmed: 19506130
Rheumatology (Oxford). 2017 Mar 1;56(3):439-444
pubmed: 27940585
Stroke. 2018 Aug;49(8):1946-1952
pubmed: 29986936
J Neurol. 2019 Jun;266(6):1481-1489
pubmed: 30904954
J Neurol. 2021 Jan;268(1):367-376
pubmed: 32813052
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
J Stroke Cerebrovasc Dis. 2020 May;29(5):104684
pubmed: 32151477
Rheumatol Int. 2011 Apr;31(4):463-72
pubmed: 20024553
J Neuroradiol. 2022 May;49(3):244-249
pubmed: 33836217
AJNR Am J Neuroradiol. 2022 Sep;43(9):E19-E35
pubmed: 35953274
Curr Neurol Neurosci Rep. 2022 Jan;22(1):47-69
pubmed: 35138587
Autoimmun Rev. 2020 Apr;19(4):102497
pubmed: 32062032
Eur Stroke J. 2021 Mar;6(1):I-LXII
pubmed: 33817340
Neurol Neuroimmunol Neuroinflamm. 2021 Oct 18;8(6):
pubmed: 34663675
J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):749-755
pubmed: 28705900
JRSM Open. 2014 Jul 08;5(8):2054270414533322
pubmed: 25289143
Arch Neurol. 1988 May;45(5):514-8
pubmed: 3358703
Stroke. 2017 May;48(5):1248-1255
pubmed: 28330942
Clin Neuroradiol. 2019 Mar;29(1):37-44
pubmed: 28875326
Stroke. 2020 Sep;51(9):2872-2884
pubmed: 32757757
Neurology. 2021 Nov 2;97(18):e1809-e1822
pubmed: 34531298
J Neurol. 1998 Dec;245(12):766-76
pubmed: 9840348
J Neurointerv Surg. 2019 Jun;11(6):535-538
pubmed: 31152058
Stroke. 2021 Oct;52(10):3308-3317
pubmed: 34233460
Cerebrovasc Dis. 2008;26(1):23-9
pubmed: 18511868
Eur Stroke J. 2021 Sep;6(3):CXXII-CXXXIV
pubmed: 34746429
Neuroradiology. 2021 Oct;63(10):1635-1644
pubmed: 33683406
J Comput Assist Tomogr. 2013 Jul-Aug;37(4):493-8
pubmed: 23863522
Clin Exp Immunol. 2014 Mar;175(3):419-24
pubmed: 24117125
Mayo Clin Proc. 2023 Feb;98(2):239-251
pubmed: 36737114
AJNR Am J Neuroradiol. 2020 Apr;41(4):624-631
pubmed: 32139427
Clin Neurol Neurosurg. 2019 Oct;185:105482
pubmed: 31421586
Am J Surg Pathol. 2009 Jan;33(1):35-43
pubmed: 18941399
Medicine (Baltimore). 2015 May;94(21):e738
pubmed: 26020379
J Clin Epidemiol. 2011 Apr;64(4):380-2
pubmed: 21185693
J Rheumatol. 1995 Apr;22(4):662-7
pubmed: 7791160
JAMA Neurol. 2016 Feb;73(2):197-202
pubmed: 26720093
Clin Rheumatol. 2014 Jan;33(1):105-10
pubmed: 24096639
Acta Radiol. 1999 Jan;40(1):83-7
pubmed: 9973909
Sci Rep. 2022 Aug 5;12(1):13494
pubmed: 35931755
Clin Neurol Neurosurg. 2017 May;156:48-54
pubmed: 28324788
Neuroradiology. 2020 Mar;62(3):283-300
pubmed: 31925469
Radiology. 2023 Jan;306(1):207-217
pubmed: 36040333
AJNR Am J Neuroradiol. 2023 Feb;44(2):E13-E14
pubmed: 36635054
Ann Neurol. 2016 Jun;79(6):882-94
pubmed: 27043703
Neuroradiology. 2016 Mar;58(3):221-35
pubmed: 26700824
Neurol Sci. 2020 Nov;41(11):3135-3148
pubmed: 32776287
Clin Neuroradiol. 2022 Dec;32(4):1045-1056
pubmed: 35503467
Clin Exp Rheumatol. 2022 May;40(4):811-818
pubmed: 35522543
Cardiovasc Diagn Ther. 2020 Aug;10(4):1108-1119
pubmed: 32968663
Ann Neurol. 2007 Nov;62(5):442-51
pubmed: 17924545
Clin Rheumatol. 2015 Apr;34(4):729-38
pubmed: 25425493
Q J Med. 1994 Jun;87(6):351-8
pubmed: 8041867
Neurol Clin Pract. 2017 Jun;7(3):256-265
pubmed: 30107009
Ann Indian Acad Neurol. 2022 Nov-Dec;25(6):1009-1018
pubmed: 36911437
Medicine (Baltimore). 1988 Jan;67(1):20-39
pubmed: 3275856
J Neurointerv Surg. 2022 Mar;14(3):209
pubmed: 35115395
AJNR Am J Neuroradiol. 2020 Nov;41(11):2075-2081
pubmed: 32883666
Neurology. 2017 Apr 11;88(15):1439-1444
pubmed: 28283598
Arthritis Rheum. 2013 Jan;65(1):1-11
pubmed: 23045170
Autoimmun Rev. 2021 Jan;20(1):102714
pubmed: 33197577
Front Neurol. 2020 Apr 16;11:287
pubmed: 32373053
AJNR Am J Neuroradiol. 2022 Jan;43(1):93-97
pubmed: 34824099
Radiology. 2004 Dec;233(3):878-82
pubmed: 15498898
Medicine (Baltimore). 2008 Sep;87(5):264-271
pubmed: 18794709
Neuroradiology. 2022 Jan;64(1):43-58
pubmed: 33938989
Radiol Case Rep. 2022 Aug 13;17(10):3927-3932
pubmed: 36032203
Stroke. 2016 Aug;47(8):2127-9
pubmed: 27354225
J Stroke Cerebrovasc Dis. 2019 Apr;28(4):920-928
pubmed: 30635219
Stroke. 2016 Sep;47(9):2401-4
pubmed: 27470990
Cureus. 2020 Dec 8;12(12):e11980
pubmed: 33425551

Auteurs

Rosario Pascarella (R)

Neuroradiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Katherina Antonenko (K)

Department of Neurology, University Hospital and University of Bern, Bern, Switzerland.

Grégoire Boulouis (G)

Neuroradiology - Diagnostic and Interventional Neuroradiology, CIC-IT 1415, INSERM 1253 iBrain, Tours University Hospital, Centre Val de Loire Region, France.

Hubert De Boysson (H)

Service de Médecine Interne, CHU de Caen, Avenue de la Côte de Nacre, Caen, France; Université Caen Normandie, Caen, France.

Caterina Giannini (C)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Mirjam R Heldner (MR)

Department of Neurology, University Hospital and University of Bern, Bern, Switzerland.

Odysseas Kargiotis (O)

Stroke Unit, Metropolitan Hospital, Ethnarchou Makariou 9, Piraeus, Greece.

Thanh N Nguyen (TN)

Neurology, Radiology, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.

Claire M Rice (CM)

Neurology, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Department of Neurology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.

Carlo Salvarani (C)

Rheumatology, Rheumatology Unit, Azienda Ospedaliera-IRCCS di Reggio Emilia and Università di Modena e Reggio Emilia, Reggio Emilia, Italy.

Antje Schmidt-Pogoda (A)

Department of Neurology with Institute of Translational Neurology, Münster University Hospital, Albert-Schweitzer-Campus 1, Münster, Germany.

Daniel Strbian (D)

Department of Neurology, Helsinki University Central Hospital HUCH, Helsinki, Finland.

Salman Hussain (S)

European Stroke Organisation, Basel, Switzerland.

Marialuisa Zedde (M)

Neurology Unit, Stroke Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH